ID: ALA377464

Max Phase: Preclinical

Molecular Formula: C8H6IN3O2

Molecular Weight: 303.06

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cc(I)ccc1N=[N+]=[N-]

Standard InChI:  InChI=1S/C8H6IN3O2/c1-14-8(13)6-4-5(9)2-3-7(6)11-12-10/h2-4H,1H3

Standard InChI Key:  QAAWZVVPVQTCBN-UHFFFAOYSA-N

Associated Targets(Human)

RyR1/FKBP12 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.06Molecular Weight (Monoisotopic): 302.9505AlogP: 3.02#Rotatable Bonds: 2
Polar Surface Area: 75.06Molecular Species: HBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.33CX LogD: 3.21
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.28Np Likeness Score: -1.07

References

1. Masuno MN, Pessah IN, Olmstead MM, Molinski TF..  (2006)  Simplified cyclic analogues of bastadin-5. Structure-activity relationships for modulation of the RyR1/FKBP12 Ca2+ channel complex.,  49  (15): [PMID:16854055] [10.1021/jm050708u]

Source